{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:49:57Z","timestamp":1791557397250,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41409-026-03006-9","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:29:30Z","timestamp":1785760170000},"page":"1303-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the conditioning armamentarium in adult acute lymphoblastic leukaemia: is treosulfan ready to challenge total body irradiation?"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-7332","authenticated-orcid":false,"given":"M. Joseph","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-8913","authenticated-orcid":false,"given":"Dinesh","family":"Bhurani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"3006_CR1","doi-asserted-by":"publisher","unstructured":"Swoboda R, Labopin M, Kr\u00f6ger N, Stelljes M, Schroeder T, Dreger P, et al. Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A matched-pair analysis from the ALWP of the EBMT. Bone Marrow Transplant 2026. https:\/\/doi.org\/10.1038\/s41409-026-02932-y.","DOI":"10.1038\/s41409-026-02932-y"},{"key":"3006_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.20.02529","volume":"39","author":"C Peters","year":"2021","unstructured":"Peters C, Dalle J-H, Locatelli F, Poetschger U, Sedlacek P, Buechner J, et al. Total body irradiation or chemotherapy conditioning in childhood ALL: A multinational, randomized, noninferiority phase III study. J Clin Oncol. 2021;39:295\u2013307.","journal-title":"J Clin Oncol"},{"key":"3006_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.775485","volume":"9","author":"K Ben Hassine","year":"2021","unstructured":"Ben Hassine K, Powys M, Svec P, Pozdechova M, Versluys B, Ansari M, et al. Total body irradiation forever? Optimising chemotherapeutic options for irradiation-free conditioning for paediatric acute lymphoblastic leukaemia. Front Pediatr. 2021;9:775485.","journal-title":"Front Pediatr"},{"key":"3006_CR4","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1182\/blood-2024-198741","volume":"144","author":"A Eichinger","year":"2024","unstructured":"Eichinger A, Szmit Z, Kleinschmidt K, Abouqateb M, Ansari M, Bader P, et al. Total body irradiation versus chemotherapy conditioning before allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia patients aged 2 to 4 years: A retrospective study of the EBMT pediatric diseases working party. Blood. 2024;144:3540.","journal-title":"Blood"},{"key":"3006_CR5","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1182\/bloodadvances.2025019142","volume":"10","author":"K Ben Hassine","year":"2026","unstructured":"Ben Hassine K, Gloor Y, Dupanloup I, Uppugunduri CRS, Mlakar V, Gonzales F, et al. Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study. Blood Adv. 2026;10:3719\u201330.","journal-title":"Blood Adv"},{"key":"3006_CR6","unstructured":"Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ (accessed 31 May2026)."},{"key":"3006_CR7","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1182\/bloodadvances.2026020149","volume":"10","author":"JJ Boelens","year":"2026","unstructured":"Boelens JJ, Dvorak CC. Yes, we can omit TBI for ALL!. Blood Adv. 2026;10:3717\u20138.","journal-title":"Blood Adv"},{"key":"3006_CR8","first-page":"S98","volume":"32","author":"H Abdel-Azim","year":"2026","unstructured":"Abdel-Azim H, Quigg TC, Kapoor N, Chi Y-Y, Baregamyan A, Higham CS, et al. Primary analysis of the endrad trial: Non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL) of children, adolescents, and young adults (CAYA) with high-risk\/relapsed B-ALL with planned comparisons to the observational cohort (pediatric transplantation and cellular therapy consortium ONC1701). Transpl Cell Ther. 2026;32:S98\u2013S99.","journal-title":"Transpl Cell Ther"},{"key":"3006_CR9","doi-asserted-by":"publisher","first-page":"e812","DOI":"10.1097\/HS9.0000000000000812","volume":"7","author":"A Spyridonidis","year":"2023","unstructured":"Spyridonidis A, Labopin M, Savani B, Giebel S, Bug G, Sch\u00f6nland S, et al. Reduced 8-Gray compared to standard 12-Gray total body irradiation for allogeneic transplantation in first remission acute lymphoblastic leukemia: A study of the acute leukemia working party of the EBMT. HemaSphere. 2023;7:e812.","journal-title":"HemaSphere"},{"key":"3006_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41409-023-01966-w","volume":"58","author":"K Hirschb\u00fchl","year":"2023","unstructured":"Hirschb\u00fchl K, Labopin M, Polge E, Blaise D, Bourhis JH, Soci\u00e9 G, et al. Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transpl. 2023;58:874\u201380.","journal-title":"Bone Marrow Transpl"},{"key":"3006_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1200\/JCO.22.00767","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang H, Fan Z, Huang F, Han L, Xu Y, Xu N, et al. Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: An open-label, multicenter, phase III trial. J Clin Oncol. 2023;41:343\u201353.","journal-title":"J Clin Oncol"},{"key":"3006_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94556-3","volume":"15","author":"M Lv","year":"2025","unstructured":"Lv M, He Y, Yang D, Ma Q, Pang A, Zhai W, et al. Total body irradiation versus chemotherapy myeloablative conditioning in B-cell acute lymphoblastic leukaemia patients with first complete remission. Sci Rep. 2025;15:10079.","journal-title":"Sci Rep"},{"key":"3006_CR13","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/cncr.28768","volume":"120","author":"S Giebel","year":"2014","unstructured":"Giebel S, Miszczyk L, Slosarek K, Moukhtari L, Ciceri F, Esteve J, et al. Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation: TBI Techniques in Current Clinical Practice. Cancer. 2014;120:2760\u20135.","journal-title":"Cancer"},{"key":"3006_CR14","unstructured":"Center for Drug Evaluation, Research. FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and pediatric patients with AML or MDS. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-treosulfan-fludarabine-preparative-regimen-allohsct-adult-and-pediatric-patients-aml-or (accessed 5 May2026). 2025."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03006-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03006-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03006-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:59:51Z","timestamp":1791554391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03006-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-03006-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}